All News
Obesity in Axial Spondyloarthritis: what are we missing beyond the scale?
Obesity in axial spondyloarthritis (axSpA) is not a minor comorbidity. Beyond the scale, there are several factors that need to be considered with obesity in axSpA.
Read Article
AI Diagnosing Rheumatic Disease?
MedPage Today
Prof. Valmed, a large language model (LLM) cleared by European regulators for medical diagnosis, outperformed human physicians for diagnosing rheumatologic conditions in terms of speed but not accuracy, a randomized trial showed.
Read Article
Osteoarthritis, Obesity and GLP-1s
https://t.co/SGnWksQBpT https://t.co/TPxM4aj7bd
Dr. John Cush RheumNow ( View Tweet)
QD Clinic: Obesity: Escalate or Reassess?
Dr. Mrinalini Dey, London, presents this QD Clinic as part of RheumNow's "The Obesity Imperative" presented in September 2026.
https://t.co/wt5N6RZmg6 https://t.co/3EyRa1WC9U
Dr. John Cush RheumNow ( View Tweet)
Physician SURVEY> When prescribing a generic, where do you refer the Patient?
Dr. John Cush RheumNow ( View Tweet)
ACP Position Statements on the Ethics of AI in Medical Practice
Recently JAMA updated its guidance on artificial intelligence (AI) in medical publications. Now, the ACP has published a position paper regarding the use and ethical considerations for the use of AI in medical https://t.co/J6qgfI2Sgt
Dr. John Cush RheumNow ( View Tweet)
Treating Obesity is Disease-Modifying (9.4.2026)
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow. New drugs approved, new drugs halted and some drugs out of control.
https://t.co/ojBOosSWMX https://t.co/K4DvUK24Pb
Dr. John Cush RheumNow ( View Tweet)
High BMI decreases the odds for MDA in PsA, esp w/ TNFi Rx (but not Inflx, IL-17i, IL-12/23i, IL-23i, JAKi). Longitudinal PsA cohort 1291 pts (mean BMI 29); Higher BMI independently assoc w/ signif. lower odds for MDA (OR 0.97), also female, age, smoking, FM & Xray damage. https://t.co/zAJ8Pmk1HY
Dr. John Cush RheumNow ( View Tweet)
Denzel Washingtons plan for self improvement - great advice to anyone starting out, looking for direction. https://t.co/0HcLyDAfNP https://t.co/DaqObRNgLW
Links:
Dr. John Cush RheumNow ( View Tweet)
Epic Cosmos study of GLP-1RA Rxs in 3.5 million children (8–11 yrs) - very few 0.6% recv a GLP-1RA (20,282 kids) - Rx went from 0.03% (2019) to 9.3% (2026-310-fold incr). More likely in older, girls, obese kids. Most GLP-1 kids had severe obesity (93.7 percent) https://t.co/JW6SXxJjA0
Dr. John Cush RheumNow ( View Tweet)
Cohort analysis shows autoimmune rheum Dz (AIRD) pts who recv COVID vax w/ boosters & updates were 41%, 71%, and 69% less likely to have COVID-related hospitalization (vs no Vax). If only initial vaccine series (without booster/updated vaccine), risk reduction was 5.6%. (n= https://t.co/NdEKKWdOAy
Dr. John Cush RheumNow ( View Tweet)
Physician SURVEY> When prescribing a generic, where do you refer the Patient?
Dr. John Cush RheumNow ( View Tweet)
Leeds study of 44 patients idiopathic inflamm myopathy (IIM) pts Rx w/ rituximab showed a 70% response 4-6 mos post RTX. Responders had higher TIS (50·0 vs 17·5). Using highly sensitive flow cytometry, @ 2 wks responders had lower #s memory B cells & Plasmablasts. Is there a role https://t.co/HTxOIxkezs
Dr. John Cush RheumNow ( View Tweet)
Swedish study of 1097 #RA pts looked at modifiable healthy lifestyle habits (HLHs: EtOH use, smoking, physical activity). At Baseline, 56% had three HLHs , unchanged (58%) at Yr 3. Nonsmoking incr 77-83%, healthy alcohol from 85%-97%. but healthy PA decr 84-71%. Lifestyle modif. https://t.co/cDyQwiN6Ae
Dr. John Cush RheumNow ( View Tweet)
ACP Clinical Guideline on Treatments of Overweight or Obese Adults
In July 2026, ACP published its first living clinical guideline addressing pharmacologic management of overweight and obesity in nonpregnant adults in outpatient settings. As this therapeutic area is rapidly https://t.co/5oQIY7J2Aw
Dr. John Cush RheumNow ( View Tweet)
Music and Pain Relief
A new scoping review in Pain Reports by Bradt et al., examines the effect of MBIs on pain management. While its efficacy is well established, how or why music relieves pain has never been fully explained. This systematic review is based on 663 records and https://t.co/HBCURxB9WC
Dr. John Cush RheumNow ( View Tweet)
EBR Journal Club: Dapirolizumab Pegol in SLE (PHOENYCS GO)
The EBR Journal Club Companion applies my adapted version of the JAMA approach to critical appraisal to an important RCT in rheumatology. Each review covers four domains: Does this apply to my patients? What is the risk https://t.co/1jAvPfRI0m
Dr. John Cush RheumNow ( View Tweet)
Join us for the first of four webinars this month!
This Journal Club will explore the TOGETHER PsA and STEP 9 trials, and what emerging evidence tells us about the complex relationship between obesity, weight loss and rheumatic disease.
The authors and leading experts will:
• https://t.co/xpnqim1VKH
Dr. John Cush RheumNow ( View Tweet)
